Reddy, Nishitha <br/><br/>
Consolidative therapy with stem cell transplantation improves survival of patients with mantle cell lymphoma after any induction regimen.  [electronic resource] 

 -  Experimental hematology  May 2012 
 - 359-66 p.  digital 
<br/><br/> Publication Type: Evaluation Study; Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1873-2399 
<br/><br/><label>Standard No.: </label>10.1016/j.exphem.2012.01.012  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antibodies, Monoclonal, Murine-Derived--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Boronic Acids--administration & dosage<br/>Bortezomib<br/>Consolidation Chemotherapy<br/>Cyclophosphamide--administration & dosage<br/>Dexamethasone--administration & dosage<br/>Disease-Free Survival<br/>Doxorubicin--administration & dosage<br/>Female<br/>Humans<br/>Kaplan-Meier Estimate<br/>Lymphoma, Mantle-Cell--drug therapy<br/>Male<br/>Middle Aged<br/>Peripheral Blood Stem Cell Transplantation<br/>Prednisone--administration & dosage<br/>Pyrazines--administration & dosage<br/>Remission Induction<br/>Retrospective Studies<br/>Rituximab<br/>Transplantation Conditioning--methods<br/>Transplantation, Autologous<br/>Transplantation, Homologous<br/>Treatment Outcome<br/>Vincristine--administration & dosage